Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
|
Investment Grade:
|
|
Comments(0)
|
(0)
|
(0)
|
Ranking History
Headlines
- The Week In Review: October Is Finally Over
Nov 02, 2008 12:12 PM
- Contract Research Organizations Being Taken to Woodshed
Oct 28, 2008 02:47 PM
- The Week In Review: Deals, Earnings And A Profile Of LEAD Therapeutics
Oct 04, 2008 08:55 PM
- WuXi PharmaTech And Covance Nix Partnership
Sep 29, 2008 01:00 PM
- Effect Of The Medicare Modernization Act on Healthcare And Allied Companies
Sep 27, 2008 05:48 PM
- Effect of the Medicare Modernization act on Healthcare and allied companies.
Sep 12, 2008 02:53 PM
- Effect of the Medicare Modernization Act on Healthcare and Allied Companies.
Sep 02, 2008 02:51 PM
- Big Pharma Effect
Aug 23, 2008 08:44 PM
- Effect of the Medicare Modernization act on Healthcare and Allied companies.
Aug 22, 2008 06:05 PM
- Bookkeeping: Creating a CRO Basket
Aug 13, 2008 12:12 PM
- Covance Inc. Invites You to Join the Webcast of Its 2009 Guidance Conference Call
Nov 24, 2008 12:45 PM
- Covance to Present at the Credit Suisse 2008 Healthcare Conference
Nov 11, 2008 06:00 PM
- Covance Inc. Invites You to Join the Webcast of Its Third Quarter 2008 Financial Results Conference Call
Oct 23, 2008 07:01 AM
- Covance Reports 3Q08 Earnings of $0.80 Per Share
Oct 22, 2008 04:28 PM
- Beacon Equity Issues Technical Trade Alerts on Medical Laboratories and Research Stocks: DGX, ERES, LH, PPDI, BRLI, CVD
Oct 22, 2008 09:20 AM
- Covance and Lilly Finalize 10-Year, $1.6 Billion Strategic R&D Collaboration
Oct 03, 2008 04:00 PM
- Covance Inc. Invites You to Join the Webcast of Its Third Quarter 2008 Financial Results Conference Call
Oct 03, 2008 11:11 AM
- Covance Decides to Pursue Its Original Preclinical Strategy in China
Sep 29, 2008 04:01 AM
- Covance To Present at the UBS Global Life Sciences Conference
Sep 22, 2008 09:03 AM
- Covance to Present at the Thomas Weisel Partners Healthcare Conference
Sep 04, 2008 09:01 AM
Analyst Ratings
|
|
Share Performance
|
Period
|
CVD
|
Compare to S&P
|
| YTD |
-54.88 %
|
-26.08 %
|
| 4 Weeks |
-21.84 %
|
-15.52 %
|
| 12 Weeks |
-57.99 %
|
-41.77 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 1.27 %
|
|
EPS Growth in Last Year: 15.94 %
|
|
Sales Growth in Last Quarter: 1.20 %
|
|
Sales Growth in Last Quarter: 12.70 %
|
|
|
